查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1825467

2025年MRI顯影劑全球市場報告

MRI Contrast Media Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年MRI顯影劑市場規模將強勁成長，到2029年將達到20.6億美元，複合年成長率為5.5%。預測期內的成長歸因於癌症患者數量的增加、慢性病盛行率的上升、研發投入和活動的增加、醫療保健支出的增加以及MRI應用的不斷擴展。預測期內的主要趨勢包括合作的加強、技術進步、產品創新、更安全、更有效的顯影劑的開發，以及製藥和生物技術公司的產品創新。

未來五年5.5%的預測成長率，較我們先前對該市場的預測略有下降0.5%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將對放射科帶來壓力，導致來自挪威和比利時的钆基顯影劑和注射劑的成本上升，從而減慢影像處理速度，並增加醫院影像中心的成本。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

預計癌症患者數量的增加將推動 MRI顯影劑市場的成長。癌症患者數量的增加歸因於許多因素，包括人口變化、生活方式選擇、環境影響、遺傳易感性和醫療保健進步。 MRI 檢查利用含钆基化合物的顯影劑，透過改變組織的磁性來增強可視化，有助於腫瘤的檢測、大小測定和表徵，以及評估腫瘤對周圍組織的侵襲。例如，根據世界衛生組織 (WHO) 於 2024 年 2 月發布的報告，預計 2022 年全球新增癌症病例數將激增至 2,000 萬，導致 970 萬人死亡。預測顯示，到 2050 年癌症病例數將大幅增加，達到 3,500 萬以上，比 2022 年估計的 2,000 萬例增加 77%。因此，癌症發生率的上升正在推動 MRI顯影劑市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球 MRI顯影劑：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球 MRI顯影劑市場：成長率分析
  • 全球 MRI顯影劑市場表現：規模與成長，2019-2024 年
  • 全球 MRI顯影劑市場預測：規模與成長，2024-2029 年，2034 年
  • 全球 MRI顯影劑：總目標市場（TAM）

第6章 市場細分

  • 全球 MRI顯影劑市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 細胞外造影顯影劑
  • 血池特工
  • 肝膽藥物
  • 全球 MRI顯影劑市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 神經系統疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 癌症檢測
  • 其他用途
  • 全球 MRI顯影劑市場：按最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷和影像中心
  • 研究機構
  • 其他最終用戶
  • 全球 MRI顯影劑市場：按細胞顯影劑類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 钆顯影劑（GBCA）
  • 钆以外的顯影劑
  • 全球 MRI顯影劑市場：依血池造影劑類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 高分子藥物
  • 基於奈米顆粒的藥物
  • 全球 MRI顯影劑市場：肝膽造影劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 肝細胞特異性藥物
  • 膽汁特異性藥物

第7章 區域和國家分析

  • 全球 MRI顯影劑市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球 MRI顯影劑市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • MRI顯影劑市場：競爭格局
  • MRI顯影劑市場：公司簡介
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Jiangsu Hengrui Pharmaceutical Co. Ltd.
  • Bracco SpA
  • Miltenyi Biotec BV & Co. KG
  • Lantheus Medical Imaging Inc.
  • Guerbet LLC
  • Curium Pharma
  • Spago Nanomedical AB
  • AMAG Pharmaceuticals Inc.
  • Nanopet Pharma GmbH
  • Trivitron Healthcare
  • Beijing Beilu Pharmaceuticals Company Limited
  • Unijules Life Sciences Ltd.
  • Taejoon Pharm Co. Ltd.
  • Mediso USA LLC
  • Nano Therapeutics Pvt. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年 MRI顯影劑市場：提供新機會的國家
  • 2029 年 MRI顯影劑市場：細分市場將帶來新機會
  • MRI顯影劑市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28561u

MRI contrast media refers to substances utilized in magnetic resonance imaging (MRI) to heighten the visibility of internal body structures. These contrast agents function by modifying the magnetic properties of tissues, thereby enhancing the contrast in resultant images.

The primary MRI contrast media products include extracellular contrast agents, blood-pool agents, and hepatobiliary agents. Extracellular contrast agents are employed in MRI to augment the visibility of internal body structures. They find application in diagnosing various conditions such as neurological disorders, musculoskeletal disorders, cardiovascular disorders, cancer detection, and more. These products are utilized by a range of end-users including hospitals, diagnostic and imaging centers, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The MRI contrast media market research report is one of a series of new reports from The Business Research Company that provides MRI contrast media market statistics, including MRI contrast media industry global market size, regional shares, competitors with an MRI contrast media market share, detailed MRI contrast media market segments, market trends, and opportunities, and any further data you may need to thrive in the MRI contrast media industry. This MRI contrast media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mri contrast media market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising demand for early diagnosis, increasing demand for diagnostic accuracy and patient outcomes, increased public awareness, development of combination imaging modalities, identification of novel use cases for contrast agents.

The mri contrast media market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise in cancer cases, growing prevalence of chronic diseases, increasing research and development investment and activities, increasing healthcare expenditure, expanding applications of MRI. Major trends in the forecast period include advancement with collaborative research, technological advancements, product innovation, development of safer and more effective contrast agents, product innovations by pharmaceutical and biotechnology companies.

The forecast of 5.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to strain radiology departments by increasing the cost of gadolinium-based contrast agents and injectable formulations sourced from Norway and Belgium, thereby delaying diagnostic imaging and elevating hospital imaging center costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in cancer cases is expected to drive growth within the MRI contrast media market. This rise in cancer cases is attributed to a multitude of factors, including demographic shifts, lifestyle choices, environmental influences, genetic predispositions, and advancements in healthcare practices. MRI scans utilize contrast agents containing gadolinium-based compounds to enhance visualization by modifying tissue magnetic properties, aiding in the detection, sizing, and characterization of tumors, as well as evaluating their invasion into surrounding tissues. For instance, a report published by the World Health Organization (WHO) in February 2024 revealed that the global estimated number of new cancer cases surged to 20 million in 2022, resulting in 9.7 million deaths. Projections indicate a substantial increase in cancer cases by 2050, with an anticipated 77% rise to over 35 million new cases, compared to the estimated 20 million cases in 2022. Hence, the mounting incidence of cancer serves as a driving force behind the expansion of the MRI contrast media market.

Key players in the MRI contrast media market are strategically focused on developing and distributing advanced products, such as macrocyclic gadolinium-based contrast agents (GBCA), to augment the diagnostic capabilities and safety profile of MRI imaging procedures. Macrocyclic gadolinium-based contrast agents (GBCA) represent a category of contrast agents utilized in medical imaging, particularly in magnetic resonance imaging (MRI). For instance, in February 2023, Guerbet, a France-based provider of MRI contrast media, unveiled the Elucirem (gadopiclenol) injection. Distinguished by its highly stable macrocyclic gadolinium-based contrast agent (GBCA), Elucirem (gadopiclenol) injection boasts the highest relaxivity in its class for MRI. This innovative formulation of gadopiclenol demonstrates exceptional efficacy in detecting and visualizing lesions with abnormal vascularity across various regions of the central nervous system and the body.

In March 2023, Bracco Imaging S.p.A., an Italy-based healthcare company, concluded the acquisition of the remaining 49% stake in Bracco-Eisai Co. Ltd. for an undisclosed sum. This strategic move is aimed at facilitating swift and adaptable responses to the evolving healthcare industry landscape, with a focus on achieving sustainable contributions to patient care through product utilization. Bracco-Eisai Co. Ltd., based in Japan, is recognized for its provision of MRI contrast media, contributing to Bracco Imaging S.p.A.'s comprehensive portfolio of healthcare solutions.

Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.

North America was the largest region in the MRI contrast media market in 2024. The regions covered in the mri contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mri contrast media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The MRI contrast media market consists of sales of gadopentetate dimeglumine (Gd-DTPA), gadodiamide, diatrizoate, and gadoversetamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

MRI Contrast Media Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mri contrast media market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mri contrast media ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mri contrast media market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Extracellular Contrast Agents; Blood-Pool Agent; Hepatobiliary Agents
  • 2) By Application: Neurological Disorders; Musculoskeletal Disorders; Cardiovascular Disorders; Cancer Detection; Other Applications
  • 3) By End-User: Hospitals; Diagnostic And Imaging Centers; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA); Non-Gadolinium-Based Contrast Agents
  • 2) By Blood-Pool Agent: Macromolecular Agents; Nanoparticle-Based Agents
  • 3) By Hepatobiliary Agents: Hepatocyte-Specific Agents; Biliary-Specific Agents
  • Companies Mentioned: Bayer AG; GE Healthcare Technologies Inc.; Fresenius Kabi AG; Fujifilm Holdings Corporation; JB Chemicals and Pharmaceuticals Ltd.; Jiangsu Hengrui Pharmaceutical Co. Ltd.; Bracco S.p.A.; Miltenyi Biotec B.V. & Co. KG; Lantheus Medical Imaging Inc.; Guerbet LLC; Curium Pharma; Spago Nanomedical AB; AMAG Pharmaceuticals Inc.; Nanopet Pharma GmbH; Trivitron Healthcare; Beijing Beilu Pharmaceuticals Company Limited; Unijules Life Sciences Ltd.; Taejoon Pharm Co. Ltd.; Mediso USA LLC; Nano Therapeutics Pvt. Ltd.; Livealth Biopharma Pvt Ltd.; BioPAL Inc.; Vitalquan LLC; Shubhra Biotech Pvt Ltd; Rege Imaging & Cine Films Private Limited; Polarean Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. MRI Contrast Media Market Characteristics

3. MRI Contrast Media Market Trends And Strategies

4. MRI Contrast Media Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global MRI Contrast Media Growth Analysis And Strategic Analysis Framework

  • 5.1. Global MRI Contrast Media PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global MRI Contrast Media Market Growth Rate Analysis
  • 5.4. Global MRI Contrast Media Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global MRI Contrast Media Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global MRI Contrast Media Total Addressable Market (TAM)

6. MRI Contrast Media Market Segmentation

  • 6.1. Global MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Extracellular Contrast Agents
  • Blood-Pool Agent
  • Hepatobiliary Agents
  • 6.2. Global MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cardiovascular Disorders
  • Cancer Detection
  • Other Applications
  • 6.3. Global MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic And Imaging Centers
  • Research Institutes
  • Other End Users
  • 6.4. Global MRI Contrast Media Market, Sub-Segmentation Of Extracellular Contrast Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gadolinium-Based Contrast Agents (GBCA)
  • Non-Gadolinium-Based Contrast Agents
  • 6.5. Global MRI Contrast Media Market, Sub-Segmentation Of Blood-Pool Agent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Macromolecular Agents
  • Nanoparticle-Based Agents
  • 6.6. Global MRI Contrast Media Market, Sub-Segmentation Of Hepatobiliary Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatocyte-Specific Agents
  • Biliary-Specific Agents

7. MRI Contrast Media Market Regional And Country Analysis

  • 7.1. Global MRI Contrast Media Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global MRI Contrast Media Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific MRI Contrast Media Market

  • 8.1. Asia-Pacific MRI Contrast Media Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China MRI Contrast Media Market

  • 9.1. China MRI Contrast Media Market Overview
  • 9.2. China MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India MRI Contrast Media Market

  • 10.1. India MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan MRI Contrast Media Market

  • 11.1. Japan MRI Contrast Media Market Overview
  • 11.2. Japan MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia MRI Contrast Media Market

  • 12.1. Australia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia MRI Contrast Media Market

  • 13.1. Indonesia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea MRI Contrast Media Market

  • 14.1. South Korea MRI Contrast Media Market Overview
  • 14.2. South Korea MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe MRI Contrast Media Market

  • 15.1. Western Europe MRI Contrast Media Market Overview
  • 15.2. Western Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK MRI Contrast Media Market

  • 16.1. UK MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany MRI Contrast Media Market

  • 17.1. Germany MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France MRI Contrast Media Market

  • 18.1. France MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy MRI Contrast Media Market

  • 19.1. Italy MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain MRI Contrast Media Market

  • 20.1. Spain MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe MRI Contrast Media Market

  • 21.1. Eastern Europe MRI Contrast Media Market Overview
  • 21.2. Eastern Europe MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia MRI Contrast Media Market

  • 22.1. Russia MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America MRI Contrast Media Market

  • 23.1. North America MRI Contrast Media Market Overview
  • 23.2. North America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA MRI Contrast Media Market

  • 24.1. USA MRI Contrast Media Market Overview
  • 24.2. USA MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada MRI Contrast Media Market

  • 25.1. Canada MRI Contrast Media Market Overview
  • 25.2. Canada MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America MRI Contrast Media Market

  • 26.1. South America MRI Contrast Media Market Overview
  • 26.2. South America MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil MRI Contrast Media Market

  • 27.1. Brazil MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East MRI Contrast Media Market

  • 28.1. Middle East MRI Contrast Media Market Overview
  • 28.2. Middle East MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa MRI Contrast Media Market

  • 29.1. Africa MRI Contrast Media Market Overview
  • 29.2. Africa MRI Contrast Media Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa MRI Contrast Media Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa MRI Contrast Media Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. MRI Contrast Media Market Competitive Landscape And Company Profiles

  • 30.1. MRI Contrast Media Market Competitive Landscape
  • 30.2. MRI Contrast Media Market Company Profiles
    • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. JB Chemicals and Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. MRI Contrast Media Market Other Major And Innovative Companies

  • 31.1. Jiangsu Hengrui Pharmaceutical Co. Ltd.
  • 31.2. Bracco S.p.A.
  • 31.3. Miltenyi Biotec B.V. & Co. KG
  • 31.4. Lantheus Medical Imaging Inc.
  • 31.5. Guerbet LLC
  • 31.6. Curium Pharma
  • 31.7. Spago Nanomedical AB
  • 31.8. AMAG Pharmaceuticals Inc.
  • 31.9. Nanopet Pharma GmbH
  • 31.10. Trivitron Healthcare
  • 31.11. Beijing Beilu Pharmaceuticals Company Limited
  • 31.12. Unijules Life Sciences Ltd.
  • 31.13. Taejoon Pharm Co. Ltd.
  • 31.14. Mediso USA LLC
  • 31.15. Nano Therapeutics Pvt. Ltd.

32. Global MRI Contrast Media Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The MRI Contrast Media Market

34. Recent Developments In The MRI Contrast Media Market

35. MRI Contrast Media Market High Potential Countries, Segments and Strategies

  • 35.1 MRI Contrast Media Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 MRI Contrast Media Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 MRI Contrast Media Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer